Best Lymphoma Experience Podcasts (2024)

1
Selecting Antiseizure Medications and Aiming for Seizure Freedom 38:05

3h ago38:05

38:05

How to achieve seizure freedom after 2 antiseizure medications (ASMs) fail? Expert insight into best practice Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001425?ecd=bdc_podcast_libsyn_mscpedu

1
Advances in Dermal Fillers: Hybrid Fillers and the Power of Regenerative Biostimulation 32:15

3h ago32:15

32:15

Learn the fundamentals of regenerative aesthetics and how hybrid fillers can help you achieve patient goals. Credit available for this activity expires: 8/15/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001440?ecd=bdc_podcast_libsyn_mscpedu

1
Treatment Goals and Targeted Therapies in Myasthenia Gravis 31:03

1d ago31:03

31:03

Are you up to date on the most recent clinical guidelines and treatment options for myasthenia gravis (MG)? Credit available for this activity expires: 8/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001404?ecd=bdc_podcast_libsyn_mscpedu

1
EHA 2024 Recap: Optimizing the Relapsed/Refractory CLL Treatment Pathway 37:22

8d ago37:22

37:22

How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_msc…

1
Midyear Highlights of Key Data From 2024 Gynecologic Cancer Conferences Informing Treatment of Ovarian, Endometrial, and Cervical Cancers 49:32

8d ago49:32

49:32

In this episode, listen to Floor J. Backes, MD, and Angeles Alvarez Secord, MD, MHSc, share their clinical insights and takeaways on new data presented for endometrial, ovarian, and cervical cancers presented at the 2024 annual meetings of the Society of Gynecologic Oncology and American Society of Clinical Oncology including: RUBY Part 1 Subgroup …

1
Managing Diffuse Large B-Cell Lymphoma at First Relapse: Optimizing Patient-Centered Care 38:15

13d ago38:15

38:15

Learn from the experts about aligning treatments with patient expectations at first relapse of diffuse large B-cell lymphoma (DLBCL). Credit available for this activity expires: 7/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001321?ecd=bdc_podcast_libsyn_mscpedu…

1
Incorporating Lipoprotein(a) Routinely Into Cardiovascular Risk Assessment: Why, What, Who, How, and When? 18:49

19d ago18:49

18:49

Learn from the experts about typical clinical scenarios, guidelines, and practical tips about lipoprotein(a) [Lp(a)]. Credit available for this activity expires: 7/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001247?ecd=bdc_podcast_libsyn_mscpedu

1
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs 34:45

22d ago34:45

34:45

In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer. Presenters: Virginia Kaklamani, MD, DSc Prof…

1
Current Clinical Practice and NCCN Guidelines for CLL/SLL 31:33

28d ago31:33

31:33

In this podcast episode, Farrukh Awan, MD, Jeremy S. Abramson, MD, MMSc, and Shuo Ma, MD, PhD, discuss real-world patient cases and how to align current clinical practice with the NCCN guidelines for CLL/SLL, including: Prognostic variables when deciding between regimens Role of MRD in CLL Results from the phase II CAPTIVATE trial Choosing among th…

1
Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today 29:49

27d ago29:49

29:49

Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date? Credit available for this activity expires: 7/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu

1
Exploring the Value of Delivering Lung Cancer Medicines in Different Ways: Optimizing the Patient Experience 41:57

1M ago41:57

41:57

New subcutaneous (SC) therapies are becoming available in lung cancer. Are you ready to talk to your patients about these? Credit available for this activity expires: 7/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001272?ecd=bdc_podcast_libsyn_mscpedu

1
Congress to Clinic: Expert Takeaways on Emerging Data for MPNs 28:35

1M ago28:35

28:35

In this episode, listen to Dr Brady L. Stein share his clinical insights and takeaways on new data for myeloproliferative neoplasms (MPNs) presented at the 2024 ASCO Annual Meeting and the EHA 2024 Congress including: Long-term survival adjusted for treatment crossover in patients with myelofibrosis (MF) treated with momelotinib vs danazol in the M…

1
CELMoDs: Spotlight on Therapeutic Approaches Targeting Protein Degradation Pathways 24:23

1M ago24:23

24:23

In this podcast episode, Julio C. Chavez, MD, MS, and Alan Skarbnik, MD, discuss the emerging role of CELMoDs in NHL care, including: Rationale for targeting CELMoDs in NHL Mechanism of action of CELMoDs Key studies and available efficacy and safety data with investigational CELMoDs in NHL Key ongoing clinical trials of CELMoDs in NHL Strategies to…

1
Latest Advances in Breast Cancer Care: Highlights From Chicago 2024 16:37

1M ago16:37

16:37

Missed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire program was made for you! Credit available for this activity expires: 7/9/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001283?ecd=bdc_podcast_libsyn_mscpedu…

1
Experts Discuss the Role of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer 24:30

1M ago24:30

24:30

In this episode, Dr Joyce O’Shaughnessy moderates a discussion with Dr Sara Hurvitz and Dr Erica Mayer answering audience questions on the latest data on incorporating CDK4/6 inhibitors into treatment plans for patients with HR+/HER2- breast cancer. Topics in this podcast include: Evidence from the monarchE and NATALEE trials of adjuvant abemacicli…

1
Congress to Clinic: Expert Takeaways on Emerging Data for AML 25:21

1M ago25:21

25:21

In this episode, listen to Professor Eunice S. Wang, MD, share her clinical insights and takeaways on new data for acute myeloid leukemia (AML) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: Data from the prospective, single-center phase Ib/II study of FLAG-IDA plus venetoclax in newly diagnosed or relapsed/refractor…

1
Congress to Clinic: Expert Takeaways on Emerging Data for MDS 19:19

1M ago19:19

19:19

In this episode, listen to Professor Courtney DiNardo, MD, MSCE, share her clinical highlights and clinical takeaways on new data for myelodysplastic syndromes (MDS) presented at the 2024 ASCO annual meeting and the EHA 2024 Congress including: COMMANDS trial of luspatercept in transfusion-dependent, erythropoietin stimulating agent–naive, very low…

1
Obesity Care: Improving Health Outcomes in Collaboration With the Patient 35:14

2M ago35:14

35:14

What impact can weight loss have on the lives of your patients living with obesity? What treatment options are available to help you help them? Credit available for this activity expires: 06/28/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001269?ecd=bdc_podcast_libsyn_mscpedu…

1
The Evolution of Incretins – A Revolution in Diabetes Management? 35:55

2M ago35:55

35:55

The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice? Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu…

1
Dengue: A Leading Cause of Travel-Related Fever – Vaccinating Travelers to Endemic Regions 20:34

2M ago20:34

20:34

Are you up to date on the risk for dengue and how to implement dengue vaccination in travelers to endemic regions? Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001216?ecd=bdc_podcast_libsyn_mscpedu

1
Unlocking the Power of Tumor-Agnostic Therapy: A Path to Personalized Cancer Care 36:04

2M ago36:04

36:04

Are you aware of the currently approved tumor-agnostic drugs? Listen to the experts as they discuss them. Credit available for this activity expires: 06/21/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001234?ecd=bdc_podcast_libsyn_mscpedu

1
Multiple Sclerosis Biosimilars in Europe: How to Communicate With Your Patient for Successful Implementation 20:17

2M ago20:17

20:17

Did you know that specific words and gestures you use can cause the nocebo effect? Credit available for this activity expires: 6/10/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000861?ecd=bdc_podcast_libsyn_mscpedu

1
A Deep Dive Into Long-Term Efficacy and Safety of LDL-Cholesterol Lowering: Modern Strategies for ASCVD 31:41

2M ago31:41

31:41

Are you up to date on low-density lipoprotein cholesterol (LDL-C)–lowering therapy in high-risk patients? Credit available for this activity expires: 06/06/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000828?ecd=bdc_podcast_libsyn_mscpedu

1
Antibody-Drug Conjugates in the Spotlight: Novel Strategies for Breast Cancer Management 37:59

3M ago37:59

37:59

Are you up to date on the key clinical data on ADCs in breast cancer -- especially those that set the stage for upcoming data releases? Credit available for this activity expires: 5/31/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000851?ecd=bdc_podcast_libsyn_mscpedu…

1
Decoding Epilepsy Treatment Strategies: A Case-Based Exploration 20:33

3M ago20:33

20:33

Combining data, guidelines, and experience to select appropriate treatments for individuals with focal epilepsy. Credit available for this activity expires: 5/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000865?ecd=bdc_podcast_libsyn_mscpedu

1
Delivering Precision Oncology to Patients: From Principles to Practice 31:31

3M ago31:31

31:31

How can molecular profiling guide cancer therapy? Join our experts to learn how to best utilize molecular testing in clinical practice. Credit available for this activity expires: 5/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001132?ecd=bdc_podcast_libsyn_mscpedu…

1
Chronic Inflammatory Demyelinating Polyneuropathy: How Insights From Disease Biology Inform Novel Therapies 32:33

3M ago32:33

32:33

Did you know that more than 20% of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) do not respond to current first-line treatments? Credit available for this activity expires: 5/30/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000839?ecd=bdc_podcast_libsyn_mscpedu…

1
Keeping Your Head Up and Fostering Strength With Matthew @MattyBowels Ulcerative Colitis Awareness & My Cancer Experience with Hodgkin's Lymphoma AYA Cancer Survivor 1:11:18

2M ago1:11:18

1:11:18

Matt dives into his experience with UC and the following topics/ themes: Having a second chance at life Surviving life weighing 101 - 111 lbs as a 5'7 male Colonoscopy/ j-pouch surgery and complications Maintaining a positive mindset Advocating for your health Finding the right medical team Power of prayer and synchronicities Fostering friendships …

1
Poverty to Abundance and Entrepreneurship Through Law of Attraction with Sabrina @betteryoubysabrina 32:26

2M ago32:26

32:26

Sabrina, Spiritual Mindset Mentor and Coach, and I have a discussion on creating reality. Tune in to learn how to work with Sabrina."Following your intuition is like walking through thick fog."From poverty to abundanceVictim mindsetBlacking out from drinkingChanging your environmentJournalingChronic anxiety and depressionListening to your intuition…

1
(2/2) The Importance of Human Connection in Marketing and Business, Dealing with Rejection, and Learning From Your Challenges w/ Danielle Becker @leftysrightmind 25:12

3M ago25:12

25:12

Part two is here! Topics include: Importance of human connection What is sourcing? Overcoming challenges and embracing the unknown How to deal with rejection Favorite collaborations Ralph Lauren Fashion Week, Marie Claire Habits and Lifestyle ZodiacsAnswering Questions:✨Advice for aspiring artists/ entrepreneurs:- How do you find yourself as an art…

1
(1/2) Growing Your Creative Agency and Turning Your Passion into a Business w/ Danielle Becker @leftysrightmind 21:32

2M ago21:32

21:32

Meet Danielle, CEO and Founder of Lefty’s Right Mind, a bespoke creative studio. IG: @leftysrightmindTopics include: Starting a career at Aeropostale, Hanes, Champion, Nike, Walmart Discovering your identity through motherhood and balancing careerLefty’s Right Mind is a full-service, bespoke atelier that brings a client’s vision to life through cre…

1
Thriving in Your 20s - Approach Health Through a Place of Love and Curiosity, Dietetics, Hormonal Balance, Blood Sugar Regulation with Ava Nouri 49:41

2M ago49:41

49:41

Topics include: Approach health through a place of love and curiosity The intentionality of food choices from a place of love, gratitude, and intention Is meat actually bad for you? Thoughts on veganism Normalizing your blood sugar to prevent hanger What a balanced meal looks like Protein powder - whey versus pea Heme versus non-here iron Build the…

1
Fine-Tuning Chronic Lymphocytic Leukemia Management: Optimising Bruton Tyrosine Kinase Inhibitor Use in Practice 34:51

3M ago34:51

34:51

What are the latest advances shaping chronic lymphocytic leukemia (CLL) treatment today? Discover the role of Bruton tyrosine kinase (BTK) inhibitors through our expert-led journey. Credit available for this activity expires: 5/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001127?ecd=bdc_podcast_libsyn…

1
Evolving Perspectives on HR-Positive Metastatic Breast Cancer: Current Understanding and New Insights 34:45

3M ago34:45

34:45

Are you up to date on the latest developments in hormone receptor-positive metastatic breast cancer? Listen to our expert panel to find out more! Credit available for this activity expires: 05/20/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000713?ecd=bdc_podcast_libsyn_mscpedu…

1
Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer 25:55

3M ago25:55

25:55

In this episode, Manali Bhave, MD; Annalise Labatut, PharmD, BCOP; and nurse practitioner Jamie L. Carroll, CNP, APRN, MSN, begin by discussing the landmark EMERALD study that led to FDA approval of elacestrant, the first oral selective estrogen receptor degrader (SERD) for treatment of hormone receptor–positive/HER2-negative metastatic breast canc…

1
SGLT2 Inhibitors in the Post-Myocardial Infarction Population: Answering the Last Unanswered Question 28:11

3M ago28:11

28:11

Are you ready to answer the last remaining question in sodium-glucose co-transporter 2 (SGLT2) inhibitor therapy for heart failure (HF)? Credit available for this activity expires: 5/13/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000749?ecd=bdc_podcast_libsyn_mscpedu…

1
Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 47:23

3M ago47:23

47:23

In this episode, Danielle M. Brander, MD; Deborah Stephens, DO; and Brian Hill, MD, PhD, discuss key aspects of the NCCN CLL guidelines and share strategies for applying these recommendations in your clinical practice to optimize treatment and outcomes. The greater discussion addresses: Optimal selection of therapy for treatment-naive CLL, includin…

1
Personalizing Care for Breast Cancer: The Precision Medicine Approach 34:42

4M ago34:42

34:42

Do you really know the optimal biomarker tests for personalizing breast cancer treatment? Are some just unnecessary? Find out from the experts! Credit available for this activity expires: 4/30/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000564?ecd=bdc_podcast_libsyn_mscpedu…

1
A Roadmap to Relief: Managing Agitation in Dementia Associated With Alzheimer's Disease 1:00:25

4M ago1:00:25

1:00:25

Do you know the symptoms that affect more than 80% of people with Alzheimer's disease in some countries? Credit available for this activity expires: 04/29/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000723?ecd=bdc_podcast_libsyn_mscpedu

1
Tailoring Bruton Tyrosine Kinase Inhibitor Strategies for CLL: Managing Today, Anticipating Tomorrow 37:49

4M ago37:49

37:49

Are you selecting the right Bruton tyrosine kinase (BTK) inhibitor for your patients with chronic lymphocytic leukemia (CLL)? Experts discuss the key differentiators and upcoming developments in the field. Credit available for this activity expires: 04/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/10007…

1
How I Treat Alagille Syndrome 36:24

4M ago36:24

36:24

Are you looking for practical advice on using ileal bile acid transporter (IBAT) inhibitors in clinical practice? Credit available for this activity expires: 4/16/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000397?ecd=bdc_podcast_libsyn_mscpedu

1
Novel Incretin-Based Dual/Triple Agonists: The Future in Diabetes Care? 20:53

5M ago20:53

20:53

How much do you know about future treatment options for type 2 diabetes (T2D)? Join Drs Vilsbøll and Nauck to find out. Credit available for this activity expires: 03/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000462 ?ecd=bdc_podcast_libsyn_mscpedu

1
Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer 48:15

5M ago48:15

48:15

In this episode, Colin C. Pritchard, MD, PhD, a pathologist, and Heather H. Cheng, MD, PhD, a medical oncologist, discuss optimal biomarker testing to guide treatment decisions in advanced prostate cancer, with topics including: Rationale for targeting PARP in prostate cancer with ARI combinations Study design nuances and findings from key randomiz…

1
Connecting the Clinical Clues of Alagille Syndrome 28:17

5M ago28:17

28:17

Do you know the key features of Alagille syndrome and how therapies that target the bile acid cycle can improve clinical symptoms? Credit available for this activity expires: 3/26/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000514?ecd=bdc_podcast_libsyn_mscpedu…

1
The Patient With Obesity in Primary Care: Novel Strategies for Sustained Weight Loss and Better Health Outcomes 17:39

5M ago17:39

17:39

Do you know how to spot when a patient needs more than lifestyle approaches for weight loss? Credit available for this activity expires: 3/1/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000272?ecd=bdc_podcast_libsyn_mscpedu

1
The Physical Implications of Stigma in People Living With HIV 32:08

5M ago32:08

32:08

What are the clinical and cellular effects of stigma in your patients living with HIV? Credit available for this activity expires: 3/13/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000379?ecd=bdc_podcast_libsyn_mscpedu

1
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer 36:29

5M ago36:29

36:29

In this podcast episode, Sara M. Tolaney, MD, MPH, and Melinda Telli, MD, delve into the critical aspects of the current therapeutic landscape for patients with unresectable or metastatic HER2-low, hormone receptor–positive, and triple-negative breast cancer, including: Challenges with the pathologic testing for HER2-low expression Optimal treatmen…

1
HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment Approaches 36:12

5M ago36:12

36:12

Listen to the experts as they share the latest findings on HER2-directed therapies in the treatment of HER2-positive metastatic colorectal cancer (mCRC). Credit available for this activity expires: 2/28/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000191?ecd=bdc_podcast_libsyn_mscpedu…

1
The Patient With High CV Risk and Obesity in Cardiology Care: Evidence-Based Strategies for Weight Loss and CV Risk Reduction 22:34

5M ago22:34

22:34

Do you know how to reduce cardiovascular (CV) risk in your patients living with obesity? What does the evidence show? Credit available for this activity expires: 3/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000273?ecd=bdc_podcast_libsyn_mscpedu

1
Unveiling the Bigger Picture of Alzheimer's Disease: From New Disease Mechanisms to Biomarkers 33:41

6M ago33:41

33:41

Do you know all there is to know beyond amyloid and tau in Alzheimer's disease? Credit available for this activity expires: 02/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000023?ecd=bdc_podcast_libsyn_mscpedu

Podcasts Worth a Listen

Lymphoma Experience Podcasts

Podcasts Worth a Listen

Quick Reference Guide